Gary Winer
Vermögen: 507 090 $ am 30.06.2026
Vermögen: 507 090 $ am 30.06.2026
Gary M.
Winer is currently an Independent Director at LENSAR, Inc. since 2018, a Director at SmartHealth Catalyzer, Inc., and a Director at Bionode LLC since 2020.
Formerly, Mr. Winer was President, Chief Executive Officer & Director at ORGENTEC Diagnostika GmbH from 2019 to 2021; President & Chief Executive Officer at AbbVie GK from 2013 to 2014; Independent Director at HCW Biologics Inc. from 2021 to 2025; Vice President-US Commercial Operations at Abbott Laboratories from 2007 to 2009; Vice President-Global Commercial Strategies at AbbVie, Inc. from 2014 to 2015; and President & Vice President at Abbott Japan LLC from 2009 to 2014.
Education includes undergraduate studies at The California State University and an MBA from Kellogg School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LENSAR INC 0,73 % | 10.06.2026 | 88 214 ( 0,73 % ) | 503 702 $ | 30.06.2026 |
HCW BIOLOGICS, INC. 0,04 % | 16.05.2025 | 679 ( 0,04 % ) | 3 388 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LENSAR, INC. | Direktor/Vorstandsmitglied | 01.04.2018 |
SmartHealth Catalyzer, Inc.
SmartHealth Catalyzer, Inc. Miscellaneous Commercial ServicesCommercial Services Builds biomedical startups | Direktor/Vorstandsmitglied | - |
Bionode, LLC
Bionode, LLC Medical/Nursing ServicesHealth Services Operates as a clinical stage glaucoma treatment company for reducing elevated intra-ocular pressure | Direktor/Vorstandsmitglied | 01.06.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| HCW BIOLOGICS INC. | Direktor/Vorstandsmitglied | 17.06.2025 |
ORGENTEC Diagnostika GmbH
ORGENTEC Diagnostika GmbH Medical/Nursing ServicesHealth Services Provides diagnostics services | Vorstandsvorsitzender | 01.01.2021 |
| ABBVIE INC. | Corporate Officer/Principal | 01.01.2015 |
AbbVie GK | Vorstandsvorsitzender | 01.04.2014 |
Abbott Japan LLC
Abbott Japan LLC Drugstore ChainsRetail Trade Manufactures and supplies pharmaceutical medicines | Präsident | 01.03.2014 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
LENSAR, Inc.
LENSAR, Inc. Medical SpecialtiesHealth Technology Develops femtosecond laser technologies for refractive cataract surgery | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott Japan LLC
Abbott Japan LLC Drugstore ChainsRetail Trade Manufactures and supplies pharmaceutical medicines | Retail Trade |
ORGENTEC Diagnostika GmbH
ORGENTEC Diagnostika GmbH Medical/Nursing ServicesHealth Services Provides diagnostics services | Health Services |
AbbVie GK | |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HCW Biologics Inc.
HCW Biologics Inc. BiotechnologyHealth Technology Develops immunotherapies for chronic, low-grade inflammation and age related disorders | Health Technology |
SmartHealth Catalyzer, Inc.
SmartHealth Catalyzer, Inc. Miscellaneous Commercial ServicesCommercial Services Builds biomedical startups | Commercial Services |
Bionode, LLC
Bionode, LLC Medical/Nursing ServicesHealth Services Operates as a clinical stage glaucoma treatment company for reducing elevated intra-ocular pressure | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen